Beneficient annual report, FY2024

Beneficient — Form 10-K Summary

Reporting period: Fiscal year ended March 31, 2024. Although the request metadata refers to 2023 Q4, this filing is an annual report for FY2024, with FY2023 comparative figures. The company provides liquidity, financing, custody and trust administration services for alternative-asset investors through its ExAlt trust structure. Its Customer ExAlt Trusts are consolidated for financial reporting, although transactions with them are eliminated and their results are substantially attributable to noncontrolling interests.

Key financial metrics

Metric	FY2024	FY2023
Consolidated revenue	$(98.7) million	$(104.9) million
Operating loss	$(2,648.5) million	$(253.2) million
Net loss	$(2,658.2) million	$(252.1) million
Net loss attributable to Beneficient common shareholders	$(2,095.6) million	$(131.0) million
Net cash used in operating activities	$(58.2) million	$(95.1) million
Net cash provided by investing activities	$44.1 million	$63.0 million
Net cash provided by (used in) financing activities	$12.6 million	$(34.5) million
Cash and cash equivalents at March 31	$7.9 million	$8.7 million

FY2024 operating expenses included a $2,354.3 million non-cash goodwill impairment and a $55.0 million arbitration loss. Goodwill fell from $2,367.9 million to $13.6 million; remaining reporting-unit fair values had no excess over carrying value.
Consolidated revenue included a $4.8 million investment gain, versus a $54.0 million investment loss in FY2023, but a $104.5 million loss on financial instruments, versus a $51.4 million loss. The reported revenue total is negative and should not be read as ordinary sales revenue.
Management’s non-GAAP adjusted revenue was $(31.2) million versus $(41.4) million; adjusted operating loss was $(115.8) million versus $(143.9) million. These measures exclude specified items and are not GAAP substitutes.
Ben Liquidity recorded $46.9 million of interest income and Ben Custody $24.5 million of trust-services and administration revenue, compared with $50.8 million and $29.0 million, respectively, in FY2023. These intercompany amounts are eliminated in consolidated statements but affect income allocated to Beneficient and BCH equity holders. The filing does not provide a clear consolidated operating margin measure.
ExAlt Loans had $559.8 million gross carrying value, a $303.6 million credit-loss allowance and $256.2 million net carrying value. Nonperforming loans were $247.5 million, or 44.21% of total loans. Allowance-to-loans rose to 54.23% from 26.04%, reflecting CECL adoption and credit deterioration.
Customer ExAlt Trust investments totaled $329.1 million, including $293.9 million of alternative-asset NAV and $35.2 million of debt and equity securities. Alternative-asset NAV declined from $385.9 million a year earlier. The loan portfolio’s estimated collateral value was $292.7 million; reported loan-to-value was 0.88.
Debt due to related parties was $120.5 million. Year-end total liabilities were $309.6 million and shareholders’ equity was a deficit of $192.1 million. The company reported $251.1 million of redeemable noncontrolling interests as temporary equity.

Material changes and developments

Net loss attributable to common shareholders increased to $2,095.6 million, chiefly because of goodwill impairment and the arbitration charge. Operating cash outflow improved by $36.9 million year over year, but remained substantial.
The CECL standard was adopted April 1, 2023. It required forward-looking lifetime loss estimates; the adoption increased the opening allowance on ExAlt Loans by $61.1 million for allocation purposes. The auditor’s opinion was unmodified, but the auditor highlighted substantial doubt about the company’s ability to continue as a going concern.
The company received $25 million under a three-year term loan in October 2023 from HH-BDH, an entity affiliated with director Thomas Hicks. Year-end debt included $94.8 million under HCLP facilities and $25.0 million principal under the HH-BDH loan. The HCLP first-lien facility was scheduled to mature September 15, 2024; the filing identifies $23.4 million of debt maturities in FY2025.
The company implemented an 80-for-1 reverse stock split on April 18, 2024, after Nasdaq bid-price noncompliance; it reported regaining bid-price compliance on May 2, 2024. Shares and per-share figures in the filing are retroactively adjusted for the split.
Under the $250 million standby equity purchase agreement (SEPA), the company had sold 503,827 shares to Yorkville by the filing date. It reported approximately $3.7 million in net proceeds to that date; further access depends on market conditions and may significantly dilute existing holders. Stockholders approved issuance beyond the prior exchange cap in June 2024.

Outlook, risks and contingencies

Going concern and liquidity: Management states that existing cash, expected operating cash flows and other available liquidity are not sufficient for contractual obligations over the next 12 months. Recurring losses, negative operating cash flow, limited cash, the arbitration award and difficulty raising capital create substantial doubt. The company expects to need additional debt or equity and is pursuing financing and settlement options, but cannot conclude those plans are probable of being implemented in sufficient amounts. It warns that failure to obtain funding or reduce near-term arbitration obligations could require it to curtail or terminate operations.
Management expects continued losses and negative operating cash flow until operations reach scale. It reported that alternative-asset distributions were below expectations in FY2024 and expected subdued distributions to continue through FY2025. The filing provides no specific revenue or earnings guidance.
The April 2024 arbitration award was $55.3 million, including pre-judgment interest, plus post-judgment interest at 10.5% annually until resolved. The company recorded a $55.0 million loss and is exploring settlement and potential legal options.
The GWG Litigation Trust filed an adversary complaint in April 2024 alleging, among other matters, fraudulent transfers, fiduciary-duty breaches and unjust enrichment tied to historical GWG transactions and seeking to avoid certain HCLP debt. Damages are not specified. A separate Paul Capital Advisors dispute could expose the company to up to $350 million plus costs if plaintiffs prevail; the standing issue is proceeding to discovery and summary judgment, with resolution targeted by January 2025.
The SEC notified the company on July 1, 2024 that its investigation had concluded and staff did not intend to recommend enforcement action; the filing notes this does not constitute exoneration and does not rule out future action. Other securities litigation and regulatory proceedings remain risks.
Principal business risks include uncertain fair values and delayed cash flows from illiquid collateral, elevated loan-loss allowances and nonperforming loans, reliance on capital markets and share issuance, Nasdaq listing risk, dilution and resale pressure, and complex related-party arrangements. The GWG Wind Down Trust held approximately 60% of Class A shares reported in April 2024; Class B shares carry 10 votes each and holders have director-designation rights.
The board approved an ExchangeTrust plan for up to $5 billion of fiduciary financings, subject to underwriting and formula-based pricing. LiquidTrust cash transactions are available only as BFF’s cash permits. Ben Insurance Services is not operational and requires regulatory approval.

Important facts for investors to verify

Current unrestricted cash, near-term obligations and the status and terms of any financing, SEPA share sales, debt refinancing or settlement of the arbitration award.
Subsequent performance and realizable value of the alternative-asset collateral, including the basis for the $303.6 million allowance, nonperforming-loan status and delayed fund distributions.
Developments in the GWG Litigation Trust complaint, Paul Capital Advisors litigation, securities cases and arbitration, including potential damages, insurance coverage and cash impact.
Post-split share count, Yorkville issuance and resale activity, dilution capacity, Nasdaq continued-listing status and voting control.
How related-party fees, preferred and guaranteed payments, BCH capital-account priorities and secured-creditor rights affect cash available to Beneficient shareholders.